Interestingly, Reinhard and co-workers indicate that the lowered mRNA expression of MMP-2 is associated with poorer prognosis and chemotherapy resistance in retinoblastoma; however, no such change was observed at the protein level of pro- or active-MMP-2. This evidence concerns the gene MMP2 and retinoblastoma.